Gene Therapy as a Novel Pharmaceutical Intervention for Stroke

被引:16
|
作者
Ooboshi, Hiroaki [1 ]
机构
[1] Fukuoka Dent Coll, Dept Med, Sect Internal Med, Fukuoka, Japan
关键词
Gene transfer; gene therapy; vector; brain; ischemia; stroke; neurogenesis; stem cell; FOCAL CEREBRAL-ISCHEMIA; PROTECTS STRIATAL NEURONS; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL GROWTH-FACTOR; TRANSFER IN-VIVO; ARTERY OCCLUSION; SUBARACHNOID HEMORRHAGE;
D O I
10.2174/138161211795164149
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cerebrovascular disease is the leading cause of death and disability in Japan and most Western countries. Gene transfer techniques may be applicable to the treatment of serious types of stroke, since several experimental studies have revealed the usefulness of gene therapy in the protection of neurons, reduction of infarct size and improvement of function. Prevention of vasospasm after subarachnoid hemorrhage is one of the best candidates for vascular gene therapy. Ischemia-induced apoptosis, inflammation, and derangement of neurovascular units can be targeted by the gene transfer approach. Recent studies have shown that promotion of neurogenesis and functional recovery may also be achieved by this strategy. Furthermore, a combination of stem cell therapy with gene transfer methods may be feasible. This review describes novel approaches for the treatment of stroke using gene transfer techniques.
引用
收藏
页码:424 / 433
页数:10
相关论文
共 50 条
  • [1] Nanoparticle-Based Gene Therapy Intervention for Stroke Treatment: A Systematic Review
    Ghasemi, Sorayya
    Alavian, Kimia
    Alavian, Firoozeh
    CURRENT GENE THERAPY, 2020, 20 (05) : 373 - 382
  • [2] Non-pharmaceutical therapies for stroke: Mechanisms and clinical implications
    Chen, Fan
    Qi, Zhifeng
    Luo, Yuming
    Hinchliffe, Taylor
    Ding, Guanghong
    Xia, Ying
    Ji, Xunming
    PROGRESS IN NEUROBIOLOGY, 2014, 115 : 246 - 269
  • [3] Neural stem cell therapy for subacute and chronic ischemic stroke
    Boese, Austin C.
    Le, Quan-Son Eric
    Pham, Dylan
    Hamblin, Milton H.
    Lee, Jean-Pyo
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [4] Targeting Astrocytes for Stroke Therapy
    Zhao, Yanxin
    Rempe, David A.
    NEUROTHERAPEUTICS, 2010, 7 (04) : 439 - 451
  • [5] A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion
    Shi, Ligen
    Rocha, Marcelo
    Leak, Rehana K.
    Zhao, Jingyan
    Bhatia, Tarun N.
    Mu, Hongfeng
    Wei, Zhishuo
    Yu, Fang
    Weiner, Susan L.
    Ma, Feifei
    Jovin, Tudor G.
    Chen, Jun
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2018, 38 (12) : 2073 - 2091
  • [6] Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke
    Hayes, Cellas A.
    Valcarcel-Ares, M. Noa
    Ashpole, Nicole M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (10) : 2475 - 2491
  • [7] Evaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from Stroke
    Craig, Amanda J.
    Housley, Gary D.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [8] Novel promising stroke therapy: new pharmacological and laser stimulation of brain clearance
    Semyachkina-Glushkovskaya, O.
    Klimova, M.
    Torres, E. Duarte
    Khorovodov, A.
    Terskov, A.
    Mamedova, A.
    Shareef, A. E.
    Saranceva, E.
    Iskra, T.
    Pavlov, A.
    Kurths, J.
    BIOPHOTONICS AND IMMUNE RESPONSES XIV, 2019, 10879
  • [9] The future of gene therapy for stroke
    Gunnett C.A.
    Heistad D.D.
    Current Hypertension Reports, 2001, 3 (1) : 36 - 40
  • [10] Triple-Gene Therapy for Stroke: A Proof-of-Concept in Vivo Study in Rats
    Sokolov, Mikhail E.
    Bashirov, Farid V.
    Markosyan, Vage A.
    Povysheva, Tatyana V.
    Fadeev, Filip O.
    Izmailov, Andrey A.
    Kuztetsov, Maxim S.
    Safiullov, Zufar Z.
    Shmarov, Maxim M.
    Naroditskyi, Boris S.
    Palotas, Andras
    Islamov, Rustem R.
    FRONTIERS IN PHARMACOLOGY, 2018, 9